BELLUS Health Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLU research report →
Range $14.75 – $14.75
Price Chart
About the company
BELLUS Health Inc. is a clinical-stage biopharmaceutical company headquartered in Laval, Canada, and founded in 1993. The firm focuses on developing therapeutic solutions for refractory chronic cough (RCC) and other related cough hypersensitivity conditions.
- CEO
- Roberto Francesco Bellini
- IPO
- 2000
- Employees
- 74
- HQ
- Laval, QC, CA
Get TickerSpark's AI analysis on BLU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.87B
- P/E
- -21.42
- PEG
- -2.10
- P/S
- 112031.09
- P/B
- 4.17
- EV/EBITDA
- -23.45
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -486768.75%
- Net Margin
- -475500.00%
- ROE
- -22.28%
- ROIC
- -19.85%
Latest fiscal year · YoY change
- Revenue
- $16.00K+0.0%
- Gross Profit
- $-3,514,736,653-58.2%
- Op Income
- $-77,883,000
- Net Income
- $-76,080,000-6.8%
- EPS
- $-0.66+26.7%
- OCF Growth
- -25.9%
- FCF Growth
- -41.0%
- 52W High
- $14.76
- 52W Low
- $6.38
- 50D MA
- $14.40
- 200D MA
- $10.11
- Beta
- -0.28
- RSI (14)
- 79
- Avg Volume
- 5.38M
No earnings-call transcripts are available for BLU yet.
- Free Float
- 72.7%
- Shares Outstanding
- 126.81M
- Float Shares
- 92.13M
of shares held by institutions
12 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Pendal Group Ltd | 127.57K | ▲ 99.24K |
Held by 1 ETFs
Biggest fund positions in BLU by dollar value.
Our BLU coverage
Recent articles, reports, and earnings notes.
No research on BLU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLU report →BLUENERGIES ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT OF UNITS FOR GROSS PROCEEDS OF C$20.7 MILLION
prnewswire.com · Jul 23
Bellus Health shareholders say yes to US$2B GSK takeover
proactiveinvestors.com · Jun 19
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
businesswire.com · Jun 16
Alliance Entertainment Reports Third Quarter and Nine Month Fiscal 2023 Financial Results
businesswire.com · May 22
BELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSK
businesswire.com · May 16
BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition
businesswire.com · May 16
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
businesswire.com · May 12
BELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023
businesswire.com · May 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.